Pediatric oncology and hematology in Manchester, England

被引：1

作者：

Eden, OB ^{[1
]}

Birch, J ^{[1
]}

Bruce, J ^{[1
]}

Campbell, RHA ^{[1
]}

Gattamaneni, HRG ^{[1
]}

Jenney, MEM ^{[1
]}

Jones, E ^{[1
]}

Kelsey, A ^{[1
]}

Lashford, LS ^{[1
]}

Stevens, RF ^{[1
]}

Will, A ^{[1
]}

机构：

[1] ROYAL MANCHESTER CHILDRENS HOSP TRUST,DEPT PAEDIAT ONCOL,MANCHESTER,LANCS,ENGLAND

来源：

PEDIATRIC HEMATOLOGY AND ONCOLOGY | 1997年 / 14卷 / 03期

基金：

英国医学研究理事会;

关键词：

D O I：

10.3109/08880019709009488

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The Manchester pediatric oncology unit is the third largest unit in the United Kingdom, with approximately 120 new referred cases per annum (10% of the U.K. total). Research activities include a gene therapy program peripheral blood stem cell studies, the genetic epidemiology of childhood cancer, late-effects research (growth, body composition, pulmonary, quality of life), psychosocial studies, and clinical trial organization. Both the clinical oncology service and research activities involve close team coordination and collaboration with scientists both within and outside Manchester. A comprehensive pediatric hematology service is provided. The unit contains the second largest children's hemophilia service in the United Kingdom, serving 200 patients with congenital blood disorders. Twenty-five bone marrow transplants are performed each year (allogenic, unrelated donor, autologous, and peripheral stem cell) for malignant and nonmalignant disorders. These activities are closely related to local, national, and international research groups.

引用

页码：191 / 197

页数：7

共 19 条

[1]

BIRCH JM, 1994, CANCER RES, V54, P1298

[2]

BIRCH JM, 1996, MED PEDIATR ONCOL, V27, P239

[3] PATTERNS AND TEMPORAL TRENDS IN THE INCIDENCE OF MALIGNANT DISEASE IN CHILDREN .1. LEUKEMIA AND LYMPHOMA [J].

BLAIR, V ;

BIRCH, JM .

EUROPEAN JOURNAL OF CANCER, 1994, 30A (10) :1490-1498

[4]

BRENNAN BMD, 1995, CLIN NUTR S2, V14, P26

[5] TREATMENT OF ADVANCED STATE T-CELL LYMPHOBLASTIC LYMPHOMA - RESULTS OF THE UNITED-KINGDOM CHILDRENS CANCER STUDY-GROUP (UKCCSG) PROTOCOL 8503 [J].

EDEN, QB ;

HANN, I ;

IMESON, J ;

COTTERILL, S ;

GERRARD, M ;

PINKERTON, CR .

BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :310-316

[6] Long-term in vitro correction of alpha-L-iduronidase deficiency (Hurler syndrome) in human bone marrow [J].

Fairbairn, LJ ;

Lashford, LS ;

Spooncer, E ;

McDermott, RH ;

Lebens, G ;

Arrand, JE ;

Arrand, JR ;

Bellantuono, I ;

Holt, R ;

Hatton, CE ;

Cooper, A ;

Besley, GTN ;

Wraith, JE ;

Anson, DS ;

Hopwood, JJ ;

Dexter, TM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :2025-2030

[7] DEVELOPING A MEASURE OF HEALTH OUTCOMES IN SURVIVORS OF CHILDHOOD-CANCER - A REVIEW OF THE ISSUES [J].

JENNEY, MEM ;

KANE, RL ;

LURIE, N .

MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (03) :145-153

[8] LUNG-FUNCTION AND EXERCISE CAPACITY IN SURVIVORS OF CHILDHOOD LEUKEMIA [J].

JENNEY, MEM ;

FARAGHER, EB ;

JONES, PHM ;

WOODCOCK, A .

MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 24 (04) :222-230

[9]

LASHFORD IS, 1995, MED PEDIATR ONCOL, V25, P275

[10] An intensive multiagent chemotherapy regimen for brain tumours occurring in very young children [J].

Lashford, LS ;

Campbell, RHA ;

Gattamaneni, HR ;

Robinson, K ;

Walker, D ;

Bailey, C .

ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 74 (03) :219-223

← 1 2 →